Overview
Lucyene Miguita practices practicing medicine in Belo Horizonte, Brazil.
Their clinical expertise encompasses Oral Squamous Cell Carcinoma, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Oral Cancer.
They are actively involved in clinical research, co-authoring 18 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lucyene Miguita
Is Lucyene Miguita a top-rated expert for Oral Squamous Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Lucyene Miguita is classified as an Experienced expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lucyene Miguita participate in research or clinical trials?
Yes. Lucyene Miguita has published 18 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Lucyene Miguita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Miguita isExperienced. Learn about COVID-19.
- Oral CancerMiguita isExperienced. Learn about Oral Cancer.
- Oral Squamous Cell CarcinomaMiguita isExperienced. Learn about Oral Squamous Cell Carcinoma.
- Severe Acute Respiratory Syndrome (SARS)